Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The World Health Organization (WHO) warned Monday that global shortages of drugs that are indicated to manage type 2 diabetes and, in some cases, approved for weight loss, also known as glucagon-like peptide 1 receptor agonist (GLP-1-RA) products, "have been associated with an increase in reports of falsified GLP-1-RA" over the past year
Do not use if safety seal is damaged or missing
In lyophilized form for research purposes, it must be reconstituted before use in laboratory protocols
Conflict of interest BG reports receiving fees for serving on an advisory board from Novo Nordisk, AstraZeneca, and MSD
Historically, natural products have demonstrated considerable potential as a source of drug discovery with the help of their chemical structure and recent endeavors on this field have focused on investigating the GLP-1 activating capabilities of various products which are naturally sourced from traditionally employed medicinal flora or nutritional origins
